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Withania somnifera, a multipurpose medicinal plant is a rich reservoir of pharmaceutically
active triterpenoids that are steroidal lactones known as withanolides. Though the
plant has been well-characterized in terms of phytochemical profiles as well as
pharmaceutical activities, limited attempts have been made to decipher the biosynthetic
route and identification of key regulatory genes involved in withanolide biosynthesis.
This scenario limits biotechnological interventions for enhanced production of bioactive
compounds. Nevertheless, recent emergent trends vis-à-vis, the exploration of genomic,
transcriptomic, proteomic, metabolomics, and in vitro studies have opened new vistas
regarding pathway engineering of withanolide production. During recent years, various
strategic pathway genes have been characterized with significant amount of regulatory
studies which allude toward development of molecular circuitries for production of key
intermediates or end products in heterologous hosts. Another pivotal aspect covering
redirection of metabolic flux for channelizing the precursor pool toward enhanced
withanolide production has also been attained by deciphering decisive branch point(s)
as robust targets for pathway modulation. With these perspectives, the current review
provides a detailed overview of various studies undertaken by the authors and collated
literature related to molecular and in vitro approaches employed in W. somnifera for
understanding various molecular network interactions in entirety.
Keywords:Withania somnifera, withanolides, tissue culture, elicitor,medicinal plant,molecular cloning, secondary
metabolites, pathway engineering
INTRODUCTION
Plants have long been known to allocate substantial resources toward developing chemical solutions
to enhance survival strategies in the form of varied natural products. These natural products
have been scrupulously used as pharmaceuticals, additives, pesticides, agrochemicals, fragrance
and flavor ingredients, food additives, and pesticides. A great majority of these plant derived
natural products have long been the basis of many traditional medicines and still they continue
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to provide mankind with new remedies. Since time immemorial
medicinal plants and their extracts have been used by humans
for the treatment of different ailments and diseases. For instance,
oils of Cedrus species (Cedar), Cupressus sempervirens (Cypress),
Glycyrrhiza glabra (Licorice), Commiphora species (Myrrh), and
Papaver somniferum (Poppy juice), all of which are still in
use today for the treatment of ailments ranging from coughs
and colds to parasitic infections and inflammation. Many of
the modern drugs against various ailments are also based
on the chemical structures of such plant derived chemical
products. During the period of 2005–2007 the Food and Drug
Administration introduced 13 new drugs of natural origin into
the market and more than 100 natural product-based drugs
are in clinical studies (Li and Vederas, 2011). Today, all drugs
used in western medicine, around 40–45% are natural products
or compounds derived from them, and of these, 25% are
obtained from plants. Moreover, the dominant role of natural
products like vinca alkaloid derivatives (etoposide, teniposide,
etoposide phosphate) acting against cancer (60%) and infectious
diseases (75%) is all the more identified (Mander and Liu, 2010).
In recent years, from a health perspective, protective dietary
constituents in the form of plant derived natural compounds
have become progressively significant part of human nutrition
research (Pandey and Rizvi, 2009; Choi et al., 2012).
Such vast range of chemical entities in the form of natural
products that do not contribute directly in growth and
development of a plant are termed as secondary metabolites.
Plant secondary metabolites like phenylpropanoids, terpenoids,
and alkaloids play significant role in plant survival under
specialized ecological conditions, e.g., biotic and abiotic stresses.
In contrast with primary metabolites, secondary metabolites are
often restricted in distribution and in many instances a specific
secondary metabolite is associated with a specific taxonomic
groups or a plant species. Medicinal plants have long been the
basis of herbal drugs for prevention and treatment of various
ailments and secondary metabolites are attributed with the
medicinal properties (Croteau et al., 2000; Rao and Ravishankar,
2002). These herbal drugs have thus been in use for thousands
of years in different cultures due to their potency, efficacy,
low cost, and fewer side-effects. With an ever-increasing global
demand for herbal medicine, there is not only requirement for
large quantity of raw material of medicinal plants, but also
of appropriate quality where active principles are available in
desired concentrations (Shahid et al., 2013). Additionally, due to
the complex chemical structures, it is often difficult to synthesize
complex natural compounds through synthetic chemistry as the
whole process is economically prohibitive. Thus, plants remain
as a sole sustainable natural resource of many medicinally
important secondary metabolites.
The biosynthesis of plant secondary metabolites is tightly
regulated by spatial and temporal cues that limit the levels
of targeted secondary metabolites in plant tissues (Dhar
et al., 2013). Furthermore, many secondary metabolites are
often species specific in distribution and the plant species in
question may be distributed to specific geographical location.
Cumulatively, these issues may limit proper exploitation of
plants for large scale production of economically important
secondary metabolites. For obvious reasons, a desirable aspect
is to improve the level of secondary metabolites in native
plant species as well as to develop alternative technologies to
produce high value bioactive compounds in microbial or yeast
heterologous hosts by using synthetic biology approaches. In
this regard, molecular biotechnological interventions and in vitro
approaches offer attractive possibilities for metabolic engineering
of plant secondary metabolites. However, biogenesis of several
important plant secondary metabolites at the level of pathway
steps and their regulation is poorly understood. These issues
can be attributed to the lack of functional genomics platforms
comprising of genome resources, mutants, and transformation
systems for medicinal plants. Hence, refinement in tools and
techniques to carry out comprehensive studies of medicinal plant
secondary metabolism is imperative.
Herein, we provide a comprehensive review of the detailed
studies carried out by the authors and other significant
contributions collated from the available literature to elucidate
different aspects of biosynthesis of steroidal lactone compounds
known as withanolides from W. somnifera, a medicinal plant of
immense repute. It also entails many important aspects related to
enhancement of withanolide production in corroboration with
molecular deciphering and in vitro approaches to understand the
regulation of withanolide production.
Withania somnifera
Withania somnifera (Solanaceae) commonly known as
ashwagandha or Indian ginseng, is a valued medicinal plant
known since antiquity (∼3000 years; Winters, 2006). It is a
commended genus described in the Indian Ayurvedic system of
medicine and also enlisted as an important herb in Unani and
Chinese traditional medicinal systems. It displays an efficient
reproductive behavior of mixed mating which enables it to
maximize benefits of both selfing as well as outcrossing. Its
breeding behavior also guarantees wide chemotypic variability
(Lattoo et al., 2007). W. somnifera is widely distributed around
the world and is mainly adapted to xeric and drier regions of
tropical and subtropical domains, ranging from the Canary
Islands, the Mediterranean region and Northern Africa to
Southwest Asia (Mirjalili et al., 2009).
Traditionally, W. somnifera is recommended to enhance
physiological endurance, overall vitality, strength and general
health. It is frequently equated with Korean ginseng (Panax
ginseng) for its restorative bioactivities. It also aids to offset
impotency, chronic fatigue, weakness, bone weakness,
dehydration, premature aging, muscle tension, and emaciation.
All parts of the plant, like leaves, stem, flower, root, seeds, and
bark are used medicinally. Root of Withania is an important
ingredient of more than 200 formulations in traditional systems
of medicine like Ayurveda, Siddha, and Unani. These systems
are being used for ages in the management of numerous
physiological ailments (Sukanya et al., 2010). The bitter leaves of
the plant have characteristic odor, used as an antihelmantic and
infusion is given in fever. In Ayurveda, berries and tender leaves
are prescribed to be applied externally to tumors, tubercular
glands, carbuncles, and ulcers (Gauttam and Kalia, 2013).
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WITHANOLIDES
W. somnifera is known to structure a wide-range of low
molecular weight secondary metabolites for example terpenoids,
flavonoids, tannins, alkaloids, and resins. It has been extensively
studied for its chemical constituents that include compounds
of diverse chemical structures viz. withanolides, alkaloids,
flavonoids, tannin (Elsakka et al., 1990; Attaurrahman et al.,
1991; Arshad Jamal et al., 1995; Choudhary et al., 2010). Of
these, withanolides are credited with widely acclaimed remedying
properties. Withanolides, with as many as 40 reported structures
represent a collection of naturally occurring C-28 steroidal
lactone triterpenoids assembled on an integral or reorganized
ergostane structure, in which C-22 and C-26 are oxidized to
form a six-membered lactone ring (Glotter, 1991; Ray and Gupta,
1994). The elementary structure is labeled as the withanolide
skeleton chemically nomenclatured as 22-hydroxy ergostane-26-
oic acid 26, 22-lactones (Misra et al., 2008). The withanolides
are generally polyoxygenated and believed to be produced via
enzyme system capable of catalyzing oxidation of all carbon
atoms in a steroid nucleus (Kirson et al., 1971; Figure 1).
The characteristic feature of withanolides and ergostane-
type steroids is one C-8 or C-9 side chain with a either
six or five membered lactone or lactol ring. This lactone
ring could be attached through a carbon-carbon bond or
through an oxygen bridge with the carbocyclic part of the
molecule (Kirson et al., 1971; Glotter, 1991). Various kinds
of structural rearrangements involving oxygen substituents like
bond scission, new bond formation, ring aromatization among
others can result in formation of novel structural variants
often described as modified withanolides or ergostane type
steroids (Misico et al., 2011). They are distributed in distinct
amounts and ratios in fruits and vegetative parts of the plant
(Sangwan et al., 2008). However, withanolides are mainly
localized to leaves, and their concentration is generally low i.e.,
ranges from 0.001 to 0.5% of dry weight basis (DWB). Many
FIGURE 1 | The basic structure of withanolide.
factors such as growth rate, geographical, and environmental
conditions are known to modulate the content of withanolides
(Dhar et al., 2013). Apart from Withania, withanolides are
also distributed to other Solanaceous genera like Iochroma,
Acnistus, Deprea, Datura, Lycium, Dunalis, Nicandra, Jaborosa,
Physalis, Salpichroa, Tubocapsicum, Discopodium, Trechonaetes,
and Witheringia. Moreover, their distribution is not restricted
completely to Solanaceous plants, withanolides have been
reported to be isolated from Taccaceae, Leguminosae (Glotter,
1991), Dioscoreaceae (Kim et al., 2011), Myrtaceae, and
Lamiaceae families including reports of isolation from marine
organisms also (Chao et al., 2011).
PHARMACOLOGY
During last two decades, there has been a notable surge in the
pharmacological based research of this plant as evidence for anti-
tumor, anti-arthritic, anti-aging, and neuroprotective properties
(Budhiraja and Sudhir, 1987; Ray and Gupta, 1994; Jayaprakasam
et al., 2003; Choudhary et al., 2005; Kuboyama et al., 2005; Kaileh
et al., 2007; Singh et al., 2011) and also positive influences on
the endocrine, cardiopulmonary, and central nervous systems
have been reported (Mishra et al., 2000). Anabalagan and
Sadique (1981) reported efficient anti-inflammatory activity of
W. somnifera as compared to hydrocortisone. W. somnifera
extracts have revealed anti-inflammatory effects in a range
of rheumatological conditions (al-Hindawi et al., 1992). W.
somnifera preparations are reported to influence the cholinergic
and GABA-ergic neurotransmission (GABA: γ-amino-butyric
acid) accounting for various central nervous system related
disorders (Kulkarni and George, 1996; Tohda et al., 2005). The
active principles, sitoindosides VII–X and withaferin A (WS-3)
significantly reduces the lipid peroxidation and increased levels
of the superoxide dismutase, catalase, glutathione peroxidase,
and ascorbic acid activity, thus possessing a free radical
scavenging property (Bhattacharya et al., 1997; Panda and Kar,
1997). Further, normal and cyclophosphamide-treated mice
showed enhanced levels of interferon-γ, interleukin-2, and
granulocyte macrophage colony stimulating factor by exhibiting
immuno-potentiating and myeloprotective effects (Davis and
Kuttan, 1999). Further, toxicity studies have shown withanolides
to be safer compounds with minute or no related toxicity (Mishra
et al., 2000). Withanolides have been noticed to enhance the
ability of macrophage to “eat” pathogens (Davis and Kuttan,
2000). WS-3 acts defending in definite types of cancers as
an inhibitor of angiogenesis (Mohan et al., 2004). Other
studies reveal that withanolides possess potent antimicrobial
potential against pathogenic bacteria, including Salmonella,
an organism associated with food poisoning (Owais et al.,
2005). Withanoside VI and withanolide A (WS-1) facilitate
the regeneration of axons and dendrites by reconstructing pre-
and post-synapses in neurodegenerative diseases and preventing
pathogenesis and neuronal death. It is found to ameliorate
the memory deficit in mice (Kuboyama et al., 2005, 2006).
Mechanistically, withanolides act as anti-inflammatory agents by
inhibiting lymphocyte proliferation, complement system, land
delayed-type hypersensitivity (Rasool and Varalakshmi, 2006).
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WS-3 is a promising agent for the treatment of the inflammatory
cascade of cardiovascular diseases as a potent inhibitor of the
pro-inflammatory transcription factors (Kaileh et al., 2007). It
exhibits in vivo anti-cancer activity against pancreatic cancer
by inhibiting Hsp90 chaperone activity and another potential
withanolide isolated from roots act as an effective agent to protect
against skin carcinoma induced by UV-B (Mathur et al., 2004;
Yu et al., 2010). Withanolidesulfoxide have been isolated and
identified to inhibit COX-2 enzyme in various tumor cell lines
and to suppress their proliferation (Mulabagal et al., 2009).
Withanolide D can be used with traditional chemotherapeutic
agents as it augments the ceramide accretion by triggering
neutral-sphingomyelinase 2, modulate phosphorylation of the
JNK and p38MAPK and induced apoptosis in both myeloid and
lymphoid cells along with primary cells derived from leukemia
patients (Mondal et al., 2010). WS-3 and withanolide D have
been demonstrated to hamper angiogenesis, Notch-1, NFκB in
cancer cells and trigger apoptosis in breast cancer cells (Kaileh
et al., 2007; Koduru et al., 2010; Hahm et al., 2011). The
oral administration of withanolides and withanosides reversed
behavioral deficits, plaque pathology, accumulation of β-amyloid
peptides (Aβ) in the animal models of Alzheimer disease through
higher expression of low-density lipoprotein receptor-related
protein in brain micro-vessels and the Aβ-degrading protease
neprilysin (Sehgal et al., 2012). Recently, WS-3 was found to
activate Cdc2 protein in prostate cancer cell lines which result
in arrest of the cell cycle and leads to cell death (Roy et al.,
2013) and the root extract have been observed to possess
neuroprotective effect against β-amyloid and HIV-1Ba-L (clade
B) induced neuro-pathogenesis (Kurapati et al., 2013). The other
withanolides and alkaloids like withasomine, cuseohygrine, and
anahygrine remain to be the promising lead-compounds for the
development of the new anti-inflammatory drugs (Mirjalili et al.,
2009).
BIOSYNTHESIS OF WITHANOLIDES
Chemically, withanolides are 30-carbon compounds called
triterpenoids. Triterpenoid backbone, like other terpenoid
compounds is biosynthesized by metabolic pathway requiring
isoprene units (isopentenylnpyrophosphate; IPP and dimethyl
allyl pyrophosphate; DMAPP) as precursors. Therefore,
isoprenogenesis could be one of the key upstream metabolic
processes governing flux of isoprene units for synthesis of
metabolic intermediate(s) of triterpenoid pathway committed to
withanolide biosynthesis (Bhat et al., 2012). Dual autonomous
pathways for the isoprenoid precursor biosynthesis co-exist in
plant cell including the classical cytosolic mevalonic acid (MVA)
pathway and the alternative route, plastidial methylerythritol
phosphate (MEP) pathway (Newman and Chappell, 1999).
Plastidial MEP pathway synthesizes IPP and DMAPP required
for production of photosynthesis associated isoprenoids
(carotenoids and side chains of chlorophylls, plastoquinones,
and phylloquinones) and hormones (gibberellins and abscisic
acid). In plants, MVA-derived isoprenoid end products comprise
of sterols (modulators of membrane architecture and plant
growth and developmental processes), brassinosteroids (steroid
hormones), dolichol (involved in protein glycosylation),
and the prenyl groups necessary for protein prenylation
and cytokinin biosynthesis (Lichtenthaler, 1999; Rodriguez-
Concepción et al., 2004). However, now there is growing
evidence that a considerable cross-talk between the two
pathways of isoprenogenesis exists and exchange of isoprene
units may occur at different sub-cellular locations (Chaurasiya
et al., 2012). A brief overview of the two metabolic routes for
isoprene biosynthesis is elucidated under following sub-sections
(Figure 2).
Mevalonate Pathway
MVA pathway involves seven enzymes for the synthesis of
precursor molecules i.e., IPP and DMAPP for terpenoid
biosynthesis. First step involves the condensation of two
molecules of acetyl-CoA into acetoacetyl (AcAc)-CoA by the
enzyme AcAc-CoA thiolase (Vranová et al., 2013) to form
3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA). In the
second step, HMG-CoA synthase facilitate condensation of
AcAc-CoA with one molecule of acetyl-CoA to form HMG-CoA
(Nagegowda et al., 2004). Subsequently, HMG-CoA reductase
(HMGR), a nicotinamide adenine dinucleotide (phosphate)-
dependent (NAD(P)H) enzyme that catalyzes a double reduction
reaction involving four electron transfers, results in biosynthesis
of mevalonate from HMG-CoA (Benveniste, 2002). Conversion
of mevalonate to IPP encompass two phosphorylations
and decarboxylation events involving mevalonate kinase,
phosphomevalonate kinase, and mevalonate diphosphate
decarboxylase enzymes, respectively. Further, IPP derived
from cytosolic MVA pathway, is acted upon by isopentenyl
diphosphate isomerase, a divalent, metal ion-requiring enzyme,
to form DMAPP (Hunter, 2007).
Methylerythritol Phosphate Pathway
First step of the MEP pathway is catalyzed by 1-deoxy-D-
xylulose 5-phosphate synthase (DXS), converting the precursors
pyruvate and glyceraldehyde 3-phosphate into 1-deoxy-
Dxylulose 5-phosphate (DXP; Sprenger et al., 1997; Cordoba
et al., 2009). DXP reductoisomerase transforms DXP into
MEP which is further converted to 1-hydroxy-2-methyl-2-(E)-
butenyl 4-diphosphate by the consecutive enzymatic action
of 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, 2-C-
methyl-D-erythritol 2,4-cyclodiphosphate synthase, and
(E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase
(HMBPP). The last step is the branching of HMBPP to
IPP and DMAPP catalyzed by the simultaneous enzymatic
action of a single enzyme, (E)-4-hydroxy-3-methyl but-2-enyl
diphosphate reductase (HDR). Although, HDR in MEP pathway
produces both IPP and DMAPP, albeit at 85:15 ratio, the plastid
localized isopentenyl diphosphate isomerase is involved in
substrate optimization by catalyzing IPP isomerization. The
head-to-tail condensation of IPP leads to formation of farnesyl
pyrophosphate (FPP). FPP is themain precursor for triterpenoids
(Kuzuyama, 2002; Chaurasiya et al., 2012) and is synthesized
by catalytic action of the enzyme farnesyl diphosphate synthase
(FPPS). It serves as a substrate for first committed reaction of
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FIGURE 2 | An overview of putative withanolide biosynthesic pathway. DXP, 1-deoxy-D-xylulose 5-phosphate; HMBDP, 1-hydroxy-2-methyl-2-(E)-butenyl
4-diphosphate; IPP, Isopentylpyrophosphate; DMPP, Dimethylalyl diphosphate; IPP isomerase, Isopentylpyrophosphate isomerase; FPPS, farnesyldiphosphate
synthase; SQS, Squalene synthase; SQE/CPR, Squalene epoxidase/cytochrome P450 reductase; CAS, Cycloartenol synthase; SMT-1, Sterol methyl
transferase/cytochrome P450 reductase; ODM/CPR, Obtusifoliol-14-demethylase/cytochrome P450 reductase. First three highlighted (yellow) steps indicating
involvement of P450 monooxygenases and CPR. Single dark arrows represent one step, two or more dark arrows represent multiple steps and dashed arrow
represents unknown steps.
Frontiers in Plant Science | www.frontiersin.org 5 November 2015 | Volume 6 | Article 1031
Dhar et al. Molecular Understanding of Witanolide Biosynthesis
several branched pathways leading to synthesis of compounds
that are essential for plant growth and development as well as
of pharmaceutical interest (Newman and Chappell, 1999). FPPS
catalyzed reaction occurs in two consecutive steps; condensation
of IPP with DMAPP to form 10-C intermediate geranyl
diphosphate (GPP) and condensation of GPP with another
molecule of IPP which results into 15-C FPP (Ohnuma et al.,
1996). Squalene is believed to be a metabolic intermediate for
biosynthesis of diverse triterpenoids. Its biosynthesis takes place
by a reaction requiring squalene synthase enzyme that catalyzes
head-to-head condensation of two molecules of FPP in NADPH
dependent manner to produce squalene. The squalene undergoes
epoxidation at one of its terminal double bonds by squalene
epoxidase yielding squalene 2,3-epoxide. A ring closure reaction
acting upon squalene 2,3-epoxide, catalyzed by cycloartenol
synthase enzyme leads to the biosynthesis of cycloartenol that
may further get converted into a variety of different steroidal
triterpenoidal skeletons (Zhao et al., 2013; Dhar et al., 2014).
The 24-methylenecholestrol, believed to be biosynthesized from
cycloartenol has been proposed to be a central intermediate
in the metabolic route toward withanolide biosynthesis. The
hydroxylation at C-22 and δ-lactonization between C-22 and
C-26 of 24-methylenecholestrol are believed to be important
reactions leading to withanolides biosynthesis (Figure 2). In
addition, it has also been suggested that α, β-unsaturated ketone
in ring A of common withanolides may be produced through
the sequential reactions. There is a scanty understanding with
respect to enzymes and genes involved in these downstream
reactions and withanolide biosynthesis.
De novo TISSUE-SPECIFIC WITHANOLIDE
BIOSYNTHESIS
Phytochemical data generated over the years support
considerable qualitative overlap of leaf and root withanolides
in W. somnifera. Gradient of withanolide concentration with
higher in leaves and lower in roots and radiotracer studies
using 24-methylene cholesterol as a precursor also hints
toward a possible import of withanolides from leaves to roots.
Nevertheless, investigations reveal incorporation of 14C from
[2–14C]-acetate and [U-14C]-glucose into WS-1 in in vitro
cultured roots and native/orphan roots of W. somnifera. This
study showed these primary metabolites being integrated into
WS-1, thus indicative of de novo synthesis of root-specific WS-1
from primary isoprenogenic precursors rather than hinting
toward an import from leaves (Sangwan et al., 2007).
Another interesting study reveals the analogy in the qualitative
and quantitative profile of withanolide accumulation in leaf and
root tissues of two morpho-chemovariants, suggesting de novo
tissue-specific withanolide biosynthesis. Two genetic stocks
designated as WS-Y-08 (25-30 cm tall with yellow berries) and
WS-R-06 (100–125 cm tall with red berries) showed appreciable
variation in their competence to synthesize and accumulate
different withanolides. Three major withanolides viz. WS-1,
withanone (WS-2), and WS-3 were assayed from leaf and root
tissues harvested at five developmental stages. Additionally,
transcript profiles of five withanolide biosynthetic pathway genes
namely squalene synthase (WsSQS; GenBank Accession Number
GU474427), squalene epoxidase (WsSQE; GenBank Accession
Number GU574803), cycloartenol synthase (WsOSC/CS;
GenBank Accession Number HM037907), cytochrome P450
reductase 1 (WsCPR1; GenBank Accession Number HM036710),
cytochrome P450 reductase 2 (WsCPR2; GenBank Accession
Number GU808569; Table 1) were also examined in the
harvested tissues. The aim was to compare gene expression
with that of metabolite flux at different phenophases. Relative
transcript abundance demonstrated significant deviation in leaf
and root tissues that was mostly parallel with the divergence in
withanolide pool. Leaves in comparison to roots showed elevated
gene expression in corroboration with improved concentration
of all the three withanolides. This relative dynamics of all the
three withanolides at quantitative and qualitative levels in the
two withanolide richest tissues possibly indicate toward de novo
tissue-specific biosynthesis (Dhar et al., 2013).
GENE ELUCIDATION OF WITHANOLIDE
BIOSYNTHETIC PATHWAY
Synthesis of withanolides chemically, is complex due to the
stereo-chemical ring closure, occurrence of chiral centers,
rigid trans-lactone groups, and high energy epoxy ring
(Neumann et al., 2008). Thus, making synthetic production
economically unworkable due to minimal yields at high costs.
Therefore, it demands viable alternatives for the production
of withanolides in large quantities for commercial exploitation.
Genetic manipulation with genes encoding enzymes involved
in withanolide biosynthesis seems to be a viable approach
that may be useful in developing genotypes of W. somnifera
with enhanced levels of withanolides as well as for withanolide
producing alternativemicrobial/yeast hosts. This whole approach
entails expression ofmetabolic circuitries in heterologous host(s).
It requires comprehensive knowledge about complete genetic
architecture of withanolide biosynthesis including enzymatic
and regulatory genes of the pathway. Nevertheless, withanolide
biosynthetic pathway still remains in its putative stage at
molecular level. Hence, it is of fundamental research value to
elucidate the withanolide biosynthetic pathway encompassing
the delineation of regulatory aspects of their biosynthesis also.
Inception of pathway exploration has gained much interest
by researchers over the past few years vis-à-vis withanolides.
There have been several endeavors by many workers including
comprehensive investigations carried out by our group related
to isolation, cloning, characterization and regulation of several
pathway genes, promoters, elicitations in corroboration with
metabolite production and substrate pool diversion for enhanced
withanolide yields. These different aspects are covered in the
ensuing text.
3-HYDROXY-3-METHYLGLUTARYL
COENZYME A REDUCTASE
3-Hydroxy-3-methylglutaryl coenzyme A reductase (3-HMGR)
is a NADH dependent rate limiting enzyme involved in the
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TABLE 1 | Putative pathway genes from Withania somnifera.
Genes involved Expression
system used
Abiotic/Biotic factors used Effect on gene/Expression and
withanolide levels
Reference
3-Hydroxy-3-methylglutaryl
coenzyme A reductase
E. coli Salicylic acid, methyl-jasmonate,
and mechanical injury
http://link.springer.com/article/
10.1007%2Fs00709-012-
0450-2
WsSGTL1/Sterolglycosyltrnasferases A. thaliana Salt, heat, and cold Increase in WsSGTL1 HSP70, HSP90,
RD29, SOS3, and LEA4-5 levels
http://www.ncbi.nlm.nih.gov/
pubmed/23646175
1-Deoxy-D-xylulose-5-
phosphate
synthase
Salicylic acid, methyl jasmonate,
mechanical injury
Maximum expression in flower and young
leaves
http://www.ncbi.nlm.nih.gov/
pubmed/22526204
1-Deoxy-D-xylulose-5-
phosphate
reductase
Salicylic acid, methyl jasmonate,
mechanical injury
Differentially expressed in different tissues http://www.ncbi.nlm.nih.gov/
pubmed/22526204
WsCYP98A E. coli Methyl jasmonate salicylic acid,
gibberellic acid
Methyl jasmonate salicylic acid increased
and gibberellic acid decreased WsCYP98
expression
http://www.biomedcentral.
com/1472-6750/14/89
WS-3 accumulation increased upon
methyl jasmonate elicitation; gibberellic
acid treatment decreased WS-3 and
WS-1 accumulation
WsCYP76A E. coli Methyl jasmonate, salicylic acid,
gibberellic acid
Methyl jasmonate, salicylic acid as positive
regulators and gibberellic acid acted as a
negative regulator for WsCYP98A
http://www.biomedcentral.
com/1472-6750/14/89
Methyl jasmonate elicitation increased
WS-3 accumulation; gibberellic acid
decreased WS-3 and WS-1 accumulation
WsCPR1 E. coli Methyl jasmonate, salicylic acid The expression remained unchanged in
WsCPR1; increase in WS-1 levels, less in
WS-2 levels
http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3578826/
WsCPR2 E. coli Methyl jasmonate, salicylic acid The treatments with methyl jasmonate,
salicylic acid resulted in induction of
WsCPR2 the expression levels
http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3578826/
WsSQS E. coli Methyl jasmonate, salicylic acid Withanolides were regulated by
methyl-jasmonate, salicylic acid and
2,4-D, treatments
http://www.ncbi.nlm.nih.gov/
pubmed/22425978
WsSQE E. coli Methyl jasmonate, salicylic acid Biosynthesis of withanolide was
up-regulated by methyl-jasmonate,
salicylic acid and 2,4-D
http://www.ncbi.nlm.nih.gov/
pubmed/23065254
Oxidosqualene cyclases (OSCs)
WsOSC/LS, WsOSC/BS,
WsOSC/CS
S. pombe Methyl jasmonate, gibberellic
acid and yeast extract
Upon methyl jasmonate treatment
transcript levels of WsOSC/LS were down
regulated, unchanged in case of
WsOSC/CS, and upregulated in case of
Bs. YE down regulated WsOSC/LS and
WsOSC/BS transcripts. gibberellic acid
induced WsOSC/BS and down regulated
WsOSC/LS transcripts
http://www.jbc.org/content/
early/2014/04/25/jbc.M114.
571919
WsDWF1 E. coli Methyl jasmonate, gibberellic
acid and 2,4-D
The treatments with methyl jasmonate,
2,4-D and salicylic acid resulted increased
expression of WsDWF1
Transcripts
WsFPPS Methyl jasmonate, salicylic acid,
mechanical injury
Maximum expression was found in flower
and young leaf and NMITLI-101
chemotype. Significant elevation in
response to salicylic acid, methyl
jasmonate and mechanical injury
http://link.springer.com/article/
10.1007%2Fs10725-011-
9578-x#page-1
conversion of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) into mevalonic acid; chief precursor of IPP and DMAPP
in the isoprenoid biosynthetic pathway. Plant HMGR have been
located in the subcellular organelles like endoplasmic reticulum
(ER), mitochondria, and plastids with catalytic domains present
in cytosolic portions of cell (Kim et al., 2015). Owing to its rate
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limiting nature this enzyme is a target of various cholesterol
lowering drugs such as statins (Istvan and Deisenhofer, 2001).
Functionally it has been characterized in both mammalian
and plant systems. In plants HMGR is encoded by multigene
family which exhibits variegated temporal and spatial expression
pattern. In Arabidopsis HMGR isozymes are encoded by
HMGR-1 and HMGR-2. Loss of function of HMGR-1 leads to
the generation of dwarf phenotype, sterility and senescence,
corresponding to the diminished sterol biosynthesis (Kim et al.,
2015). Considering its important role in isoprenoid biosynthesis
HMGR has been explicitly studied and characterized in many
plant and other plant species which include Catharanthus roseus,
Ginkgo biloba, Taxus media, Salvia miltiorrhiza, etc. (Akhtar
et al., 2013).
Studies carried out have shown the existence of a relationship
between withanolide biosynthesis and HMGR-1 expression. In
this study a positive correlation between high transcript levels of
HMGR and optimum accumulation of withanolides was found
in the root tissue of W. somnifera (Table 1; Akhtar et al., 2013).
It may be attributed to the enhanced biosynthesis of substrate
pool or precursors like IPP and DMAPP for various biosynthetic
pathways including withanolide biosynthetic pathway. Also
reports of HMGR-1 mutants generating diminished sterol
content in A. thaliana and mevinolin directed inhibition of
HMGR leading to significant decrease in total ginsenoside in
P. ginseng adventitious roots (Kim et al., 2015) suggest a link
between HMGR-1 expression and sterol biosynthesis. Positive
elicitation i.e. increased expression of WsHMGR in response
to salicylic acid (SA) and methyl jasmonate (MJ) indicates
presence of cis regulatory elements in promoter region which
may regulate the expression ofWsHMGR in various biosynthetic
pathways including withanolide biosynthetic pathway. Young
leaves expressed high levels of WsHMGR transcripts than in
mature leaves (Chaurasiya et al., 2007). These results correlated
positively with the enhanced levels of withanolide production in
young leaves relative to that of mature leaves of W. somnifera.
HMGR has been demonstrated as an accelerator of isoprenoid
biosynthesis. There was two-fold increase in the biosynthesis of
β-carotene in E. coli (Akhtar et al., 2013) by tandem expression of
WsHMGR and PAC Beta gene. It suggested that HMGR provides
enhanced progenitor substrate pool for various biosynthetic
pathways including withanolide biosynthesis.
1-DEOXY-D-XYLULOSE-5-PHOSPHATE
REDUCTOISOMERASE AND
1-DEOXY-D-XYLULOSE-5-PHOSPHATE
SYNTHASE
Plausibly, withanolides, the signature secondary metabolites of
W. somnifera, are biosynthesized through metabolic deviation
from sterol pathway at the level of 24-methylene cholesterol
(Sangwan et al., 2004). Isoprenoid precursor for the same
is synthesized by MVA pathway and MEP pathway wherein
MEP pathway is the plastid-derived alternative route for
isoprenoid biosynthesis. MEP pathway contributes about 30%
in biosynthesis of withanolide precursor isoprenoids (Tuli et al.,
2009) in which the first step is a condensation of pyruvate
with Dglyceraldehyde-3-phosphate to form 1-deoxy-D-xylulose-
5-phosphate (DXP), catalyzed by DXP synthase (DXS). DXP
acts as a precursor for IPP and DMAPP biosynthesis (Julliard
and Douce, 1991; Julliard, 1992; Himmeldirk et al., 1996).
Subsequently, conversion of DXP to MEP, is catalyzed by
DXP reductoisomerase (DXR). Though, DXR is the opening
committed step for terpenoid biosynthesis through the MEP,
DXS, the first enzyme of this pathway, also is significant
for isoprenoid biosynthesis in several organisms, including
bacteria and plants (Estévez et al., 2001; Guevara-García et al.,
2005). To understand the significance of MEP pathway in
isoprenoid biosynthesis in Withania, full-length cDNAs of
WsDXS and WsDXR were cloned and characterized (Table 1).
Saptial expression analysis revealed elevated level ofWsDXS and
WsDXR transcripts in young leaf that correlates with the reported
enhanced rates of withanolide biosynthesis in young than in
mature leaf of W. somnifera (Chaurasiya et al., 2007). Lower
root expression of WsDXS and WsDXR than leaf also hinted
toward their plastid-localization. This hints toward root being
less active site for isoprenoid biosynthesis utilizing substrate
from MEP pathway. Though, leaves and roots both are involved
in withanogenesis independently, leaves are possibly the prime
site for the same. Further, gene expression level of WsDXR
and WsDXS were corroborated with qualitative and quantitative
withanolide variations in chemotypes NMITLI-101, NMITLI-
118, and NMITLI-135 possessing WS-3, WS-2, and withanolide
D as the main withanolides in leaf tissue and withanolide A as the
main withanolide in the root tissue.WsDXS expressed maximally
in leaf of NMITLI-118 and 135 which was concurrent with
high accretion of withanolides in these chemotypes. Conversely,
expression of WsDXR transcript was observed approximately
equivalent in leaves of all three chemotypes. Consequently,
indicating that enzymes contribute in similar manner during
isoprenoid biosynthesis in different chemotypes (Gupta et al.,
2013a).
FARNESYL DIPHOSPHATE
MVA andMEP pathway are attributed with most of the bioactive
molecules synthesized in Withania. In these biosynthetic routes,
farnesyl diphosphate (FPP), acts as a substrate for foremost
committed reaction of numerous branched pathways and
is synthesized by the enzyme farnesyl diphosphate synthase
(FPPS) in two successive steps. Firstly, condensation of IPP
with DMAPP structures 10-C intermediate geranyl diphosphate
(GPP). Further condensation of GPP with another molecule of
IPP forms FPP. FPPS is an important enzyme for biosynthesis
of isoprenoid that synthesize sesquiterpene precursors for
vital metabolites including sterols, dolichols, ubiquinones, and
carotenoids in addition to substrates for farnesylation and
geranylgeranylation of proteins. Overexpression of ginseng
farnesyl diphosphate synthase in Centella asiatica hairy roots
also enhanced phytosterol and triterpene biosynthesis (Kim
et al., 2010). FPPS as well caters an important role in incipient
steps of triterpenoid precursor production related to withanolide
biosynthesis. Consequently, highlighting the significance of FPPS
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in any pathway engineering attempt for enhancing a desired
isoprenoid of primary or secondary importance. FPPS has
been characterized from a range of different plant species like
Arabidopsis (Closa et al., 2010), Artemisia (Matsushita et al.,
1996), Hevea (Takaya et al., 2003), maize (Cervantes-Cervantes
et al., 2006), etc. As a step toward elucidating the significance
of FPPS as the key entry point enzyme of the withanolide
biosynthesis in W. somnifera, full-length FPPS cDNA was
isolated and characterized as it constitutes a key step en route
to biosynthesis of the progenitor(s) of withanolide biosynthesis
(Table 1). Significance of WsFPPS gene in synthesis of sesqui-
and higher isoprenoids counting the metabolites obtained from
them was displayed by the constitutive expression of WsFPPS
in all parts of the plant. Higher expression level of WsFPPS
in young leaf as compared to the mature leaves corroborated
with the reported enhanced withanolide biosynthesis in young
leaf of W. somnifera (Chaurasiya et al., 2007; Gupta et al.,
2011).
SQUALENE SYNTHASE
Squalene synthase (SQS) (farnesyl diphosphate: farnesyl
diphosphate farnesyl transferase, EC 2.5.1.21) catalyzes one of
the initial enzymatic steps of phytosterol biosynthetic pathway,
facilitating condensation of two farnesyl pyrophosphate
molecules to squalene. SQS routes carbon flux from isoprenoid
pathway toward the phytosterol biosynthesis resulting in
formation of endproducts like brassinosteroids, withanolides,
and triterpenoids (Abe et al., 1993). SQS has been reported to
be active in ER, it anchors to it via carboxyterminal portion.
The cytosolic portion is anchored via amino terminal of protein
(Robinson et al., 1993). SQS plays a key regulatory function
in phytosterol biosynthesis. Overexpression of SQS genes in P.
ginseng (Lee et al., 2004) and Eleutherococcus senticosus (Seo
et al., 2005) led to the improved accretion of phytosterols and
triterpenes thus highlighting the significant regulatory function
of SQS in plants. Although ample evidence is available regarding
the role of SQS in phytosterol biosynthesis, scanty is identified
about the biosynthetic pathway of withanolides, genes involved
in the withanolide biosynthesis and regulatory elements of
promoter region governing the gene expression inW. somnifera.
Thus, for pathway intensification leading to enhancement of
withanolide accumulation in W. somnifera Bhat et al. (2012)
investigated the significance of squalene synthase in withanolide
biosynthesis. Characterization ofWsSQS including tissue specific
expression analysis and regulatory studies at promoter level
substantiated WsSQS as an imperative gene target involved
in withanolide biosynthesis (Table 1). WsSQS demonstrated
increased expression pattern in leaves that was in consonance
with the elevated production of withanolides in leaves of W.
somnifera. Additionally, biosynthesis of withanolides and
mRNA abundance of WsSQS were enhanced through diverse
signaling molecules including methyl-jasmonate, salicylic
acid, and 2,4-D that was regular with the expected results of
WsSQS promoter. Thus, hinting toward the unraveling of a key
committed step of the withanolide biosynthetic pathway (Bhat
et al., 2012).
SQUALENE EPOXIDASE
Squalene epoxidase (SE) (EC 1.14.99.7) is a rate limiting enzyme
in the sterol biosynthetic pathway, catalyzing the conversion of
squalene into 2,3-oxidosqualene by carrying out stereospecific
epoxidation reaction (Ryder, 1992; He et al., 2008). This
enzyme requires cytosolic (S105) fraction, molecular oxygen,
NADPH-cytochrome c reductase, NADPH and flavine adenine
dinucleotide (FAD) for its activity (Abe et al., 2007). SQE, a lightly
bound FAD flavin, attains electrons from NADPH-cytochrome
reductase, instead of binding the nicotinamide cofactor directly
which differentiates it from other flavin mono-oxygenases. It is
mainly located in the endoplasmic reticulum and lipid droplets
but protein located in the endoplasmic reticulum is active (Leber
et al., 1998). Additionally, SQE activity can result in the formation
of 6,7-oxidosqualene, 10,11-oxidosqualene, and dioxidosqualene
(Bai and Prestwich, 1992). SQE has been found to be main
precursor for all identified angiosperm cyclic triterpenoids,
that comprise membrane sterols, non-steroidal triterpenoids,
brassinosteroid, and phytohormones. Being a rate limiting
enzyme SQE has a cascading influence on the upregulation of
downstream genes (Han et al., 2010). Thus, genetic manipulation
of SQE in host plant offers an exciting prospect for production
of desired therapeutic triterpenoid molecules (Takemura et al.,
2010). This has been demonstrated in P. ginseng for heightened
synthesis of triterpene saponins and phytosterols using squalene
synthase (Lee et al., 2004). Against this backdrop, Razdan
et al. (2013) has reported the substantial notice to comprehend
the regulatory function of SE in withanolides biosynthesis.
Toward this goal, WsSQE gene along with its promoter was
isolated from W. somnifera and several cis-regulatory elements
of promoter region were revealed (Table 1). This paves a way
to recognize the regulatory function of SQE in withanolides
biosynthesis as WsSQE also displayed maximum expression in
withanolide richest leaf tissue. Keeping in view the prospect
of pathway intensification, significance of WsSQE as a robust
target lies in its rate limiting nature (Razdan et al., 2013).
This significance can be utilized with an efficient Agrobacterium
mediated transformation system inW. somnifera for homologous
modulation of withanolide biosynthesis.
CYCLOARTENOL SYNTHASE
Withanolides are synthesized via both MVA and MEP pathways
which direct the flux of the isoprene (C5) units for the synthesis
of triterpenoid pathway intermediates which are further
committed to withanolide biosynthesis. Sterols, withanolides,
and various triterpenoids are synthesized through a common
30-carbon intermediate 2,3-oxidosqualene in a highly regio
and stereo-specific step catalyzed by a family of genes called
oxidosqualene cyclases (OSCs) (Phillips et al., 2006). Plants
produce a variety of triterpenoid skeletons structured by
numerous OSC enzymes broadly belonging to two groups i.e.,
protosteryl and dammarenyl cations based on the nature of
their supposed catalytic intermediates (Phillips et al., 2006).
Both these cations as backbones impart discrete stereochemistry
and ring configurations to various triterpenes. The protosteryl
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cation with chair-boat-chair (C-B-C) configuration forms
cycloartenol, lanosterol, cucurbitadienol, and parkeol tetracyclic
triterpene structures. The majority of the pentacyclic triterpenes
are however, derived from the dammarenyl cation by D-ring
expansion to form lupeol or further E-ring expansion to form
β-amyrin (Xu et al., 2004). Similarly, partitioning of the common
substrate, 2,3-oxidosqualene inW. somnifera takes place between
OCS-cycloartenol synthase [(S)-2,3-epoxysqualene mutase
(cyclizing, cycloartenol forming), EC 5.4.99.8] (CAS) and other
OSCs. CAS forms cycloartenol, a pentacyclic triterpene with
nine chiral centers and functions as the precursor to phytosterols
and apparently to withanolides and other diverse OSCs structure
diverse triterpenoids like lupeol, beta amyrin, etc., (Rees et al.,
1969). This partitioning constitutes a metabolic branching
point leading to the division of 2,3-oxidosqualene between
sterol/withanolides and range of triterpenoids (Figure 1). Thus,
making genes covering the branches of these sub-dividing point
prospective candidates for perturbation. Such manipulations
hold significant possibility of impacting respective branch flux by
redirecting the precursor reservior in the direction of preferred
secondary compound and concurrently reduce the flux via
competitive biosynthetic routes. Against this backdrop, in W.
somnifera three members of OSC superfamily viz. β-amyrin
synthase (WsOSC/BS; GenBank Accession Number JQ728553),
lupeol synthase (WsOSC/LS; GenBank Accession Number
JQ728552), and WsOSC/CS covering three branches of a sub-
dividing junction leading to withanolides, sterols and a suite
of triterpenoids have been characterized (Table 1). Regulatory
studies of WsOSCs involving plant-derived methyl jasmonate
and giberrelic acid and microbe-derived yeast extract elicitations
displayed differential transcriptional and translational profiles
that were clearly reflected in visible variations in withanolide
quantity. MJ elicitation considerably augmented WS-3 accretion
over a period of 48 h that was in consonance with studies
involving MJ-induced up-regulation of WsSQS, WsSQE, and
WsCPR2mRNA also led to enhanced withanolide accumulation.
It may be attributed to increased synthesis of 2,3-oxidosqualene
produced by induced upstream genes. As a consequence,
WsOSC/CS is able to utilize an increased precursor pool for
withanolide biosynthesis. Although the OSC mRNA expression
model in case of gibberellic acid (GA3) coincided with MJ
treatment, the total withanolide accumulation demonstrated a
regular drop with increasing time course. This may be attributed
mainly to the decrease in WsOSC/CS protein concentration as
evident from the Western blot study. Nevertheless, transcript
abundance of WsOSC/BS showed a rise that hinted toward
the decrease in the total substrate availability for WsOSC/CS,
but at the protein level, WsOSC/BS expression declined with
increasing time intervals, thus possibly substantiating the
drop in WS-3 concentration caused by decreased WsOSC/CS
protein availability. Interestingly, microbe-derived exogenous
yeast extract (YE) elicitor played a role of negative regulator
for the two competitive OSCs of WsOSC/CS (WsOSC/BS
and WsOSC/LS) at both the protein and mRNA levels,
whereas WsOSC/CS showed no change in its transcript or
protein expression in response to YE. However, there was
significant increase in withanolide concentration with YE
in comparison with MJ treatment. The down-regulation of
WsOSC/BS and WsOSC/LS is possibly indicative of differential
channeling of common substrate among the three branch
OSCs. Plausibly, this leads to rearrangement of metabolic fluxes
wherein bulk of 2,3-oxidosqualene substrate pool shifts toward
WsOSC/CS, leading to much improved withanolide yields. The
characterization and validation of WsOSCs seem important for
strategizing the enhanced production of withanolides (Dhar
et al., 2014).
CYTOCHROME P450 REDUCTASE AND
MONOOXYGENASES
Cytochrome P450 enzymes, member of one of the key
functionally diverse protein super-families. It is essential
in a variety of metabolic molecular circuitries. P450s are
heme thiolate-proteins, catalyse enormously varied reactions
like hydroxylations, dealkylations, sulfoxidations, epoxidations,
reductive dehalogenations, peroxidations, and different types
of isomerization for the synthesis of a number of primary
and secondary metabolites indispensable for plant growth
and development (Guengerich, 2001a; Hrycay and Bandiera,
2012). P450 monooxygenases comprise a substrate explicit
class of enzymes which are highly regio and stereo-specific.
Gene annotation has shown that about 1% of the entire
genes in the plant’s genome are cytochrome P450s. Arabidopsis
genome contains 244 genes and 28 pseudo-gene representing
cytochrome P450s (Nelson et al., 2004). P450s are ER localized
with their catalytic functioning depending on source of
electrons through NADPH cytochrome P450 reductase (CPR:
diflavoenzyme).
CPRs (EC 1.6.2.4) possess a N-terminal positioned flavin
mononucleotide (FMN) binding domain linked to NADPH
binding domain via flavin adenine dinucleotide (FAD) domain
are membrane bound proteins localized to ER. These are
responsible for shuttling electrons obtained from NADPH
through FAD and FMN domains into the heme iron-center
of the various P450 enzymes. CPR genes have been isolated
from numerous species of yeast, animals and insects. Between
all, only one form is identified to network with several P450s
(Simmons et al., 1985). Conversely, many CPR paralogs varies
based on the vascular plant species. Ro et al. (2002) have
categorized CPRs into Class I and class II groups on the
basis of N-terminal anchoring sequences. CPR1 belonging to
class I expresses constitutively whereas CPR2 in class II, is
expressed in stress or on wound elicitation. Plants encode several
CPRs that reflects the range of P450s (Werck-Reichhart et al.,
2000; Feldmann, 2001) and their role in primarily confronting
the elevated requirement of electrons during various stresses
or varied expression at different plant developmental stages
(Mizutani and Ohta, 2010).
Additionally, P450 monooxygenases also correspond to a
highly regio and stereo-specific class of fixed substrate-specific
enzymes that play a decisive function in secondary metabolism
and mostly aid in functionalizing core structures of molecules
like withanolides. Due to their regio and stereo-specific catalyzing
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flexibility, these are possible targets for industrial biocatalysis.
P450s have been useful in industry for the examination of new
medicine, drugs or xenobiotics (Guengerich, 2002, 2011; Miners,
2002). P450s are considered as the most versatile biological
catalysts in nature due to the notable diversity of chemical
reactions catalyzed and vast substrates attacked (Sono et al., 1996;
Guengerich, 2001b; Coon, 2005). Consequently, accentuating
their identification and characterization for biosynthetic pathway
elucidation. Due to the polyphyletic nature of plant P450s
these are commonly categorized in two main clades, A-type
and non-A-type. Plant specific metabolism and biosynthesis of
diverse natural products involves A-type P450s (Bak et al., 2011).
The molecular and biochemical characteristics of cytochrome
P450 reductases and monooxygenases in relation to pathway
engineering, emphasizes the significance of this family of genes
as robust gene targets of both primary and secondary metabolite
biosynthesis.
Molecular and biochemical studies started to reveal
biosynthetic routes for several withanolides in W. somnifera
encompasses this important family of genes. Two A-types P450
WsCYP98A (GenBank Accession Number HM585369) and
WsCYP76A (GenBank Accession Number KC008573) and two
paralogs of cytochrome P450 reductases from W. somnifera
have been isolated, sequenced and heterologously expressed in
E. coli (Rana et al., 2013, 2014) (Table 1). All the four CYPs
at transcript level are spatially regulated displaying variance
in tissue specificity. Expression of WsCPR2 is coincident with
the elevated withanolides content in W. somnifera leaves.
This probably indicates involvement of WsCPR2 to confront
increased reductive demand of diverse P450 monooxygenases
for carrying the withanolides biosynthesis. Elicitation studies
showed exogenous elicitors acting as both positive and negative
regulators of mRNA transcripts of Ws monooxygenases and
reductases. MJ and SA resulted in abundant WsCYP98A and
WsCYP76A expression. Increased mRNA levels also agreed
with the high accumulation of elicitation driven withanolides
biosynthesis. There was appreciable enhancement in WS-1
and WS-3 in response to elicitations. In MJ treated samples,
there was a 2.5-fold increase in WS-1 and a significant 4.2-fold
enhancement of WS-3. SA treated samples showed marked
increase of 1.7- and 3.2-fold in WS-1 and WS-3, respectively.
Conversely, GA3 decreased the expression of WsCYP98A as
WsCYP76A in addition to the gradual decline in WS-3 whereas
WS-1 showed an increase up to 24 h followed by a decrease
in WS-1 after 48 h (Rana et al., 2014). Whereas, MJ and SA
elicitation induced only WsCPR2 reductase while as WsCPR1
expression showed no change along with significant increase in
WS-1 and WS-3 (Rana et al., 2013).
Additionally, four more CYP genes from W. somnifera
christened as WSCYP93Id, WSCYP93Sm, WSCYP734B, and
WSCYP734 belonging to CYP83B1 and CYP734A1 family and
CYP71 and CYP72 clans, also displayed variance in expression
in different tissues and in response to different treatments.
Interestingly, all the four CYPs showed maximal expression in
leaf tissue that was co-incident with the tissue specific secondary
metabolite profile of W. somnifera. Furthermore, similar
expression profile of WSCYP93Id, WSCYP93Sm, WSCYP734B
and WSCYP734 in different W. somnifera chemotypes hinted
toward their specialized role in biosynthesis of chemotype-
specific metabolites. Light and auxin led to enhancement in
expression of all the four CYPs. However,WSCYP734B displayed
predominant responsiveness to light and auxin proposing
its association with withasteroid/brassinosteroid regulation in
planta. MJ and SA elicitations showed an increasing m-RNA
abundance trend of the CYPs with increasing concentration
of the elicitor. Functional validation of WSCYP93Id in E.
coli using withanolides as substrates revealed change of
withaferinA to a hydroxylated product. Relationship chart drawn
for WSCYP93Id, WSCYP93Sm, WSCYP734B, and WSCYP734
sequences proposed that various withanolides like withanolide
A, withanolide D, withaferin A, and withanone are possibly
the ensuing yields of metabolic changes involving downstream
biosynthetic genes by means of WSCYP enzymes (Srivastava
et al., 2015).
Likewise, these results cumulatively, give a better
understanding of the regulatory role of CPRs for increased
production of withanolides by means of Agrobacterium
mediated transformation system. This can lead to homologous
intensification of overall metabolite flux with higher transcript
levels of key regulatory genes correspondingly up-regulating
downstream genes.
GLUCOSYLTRANSFERASES
Plant metabolism involves glycosylation as a common
modification reaction that is perpetually related with secondary
metabolism. Enzymes leading to glucoside formation are
called as uridine diphosphate glycosyltransferases (UGTs),
members of family 1 of the glycosyltransferase superfamily,
which contains over 80 families of enzymes (Campbell et al.,
1997; Coutinho et al., 2003) and their functioning involves
transferring a uridine diphosphate (UDP)-activated glucose
to an equivalent acceptor molecule. UGTs use UDP-activated
sugars as donors and allocate their sugar moiety to many
acceptors. Plant family 1 UGTs catalyse the glycosylation of
surplus bioactive natural compounds. This is frequently the
concluding step for biosynthesis of various natural products
(Jones and Vogt, 2001), to improve their stability and solubility,
and to facilitate storage and build-up in plant cells. Over the
years, many UGT gene sub-families have evolved for molecular
glycosylation (Vogt and Jones, 2000; Jones and Vogt, 2001).
UGTs functioning in secondary metabolism carry a conserved 44
amino acid residue motif (60–80% identity) called as the plant
secondary product glucosyltransferase box (PSPG), validated to
include the UDP–sugar binding moiety (Hughes and Hughes,
1994; Offen et al., 2006). Nevertheless, UGTs show comparatively
meager levels of sequence identity, particularly in the regions
associated with acceptor binding. This might be important for
the recognition of many acceptors and synthesis of huge number
of products.
Many of the pharmacological properties of W. somnifera
are attributed to its distinctive steroidal compounds, called
glycowithanolides (Matsuda et al., 2001; Singh et al., 2001; Misra
et al., 2005; Lal et al., 2006). However, there exists scarcity in
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the information related to the metabolic step(s) leading to their
glyco-transformations due to non-availability of the relevant
enzymes and genes.
The first study on sterol glucosyltransferases (SGTs) from W.
somnifera reported three different (SGTs) SGTL1, SGTL2, and
SGTL3 comprising conserved SGT family domains (Table 1).
Among these, SGTL1 was cloned in full length (DQ356887)
and was found to be ubiquitously expressing in different parts
of the plant. Deduced amino acid sequence of SGTL1 showed
the presence of transmembrane domains and preference for
membrane sterol glucosylation. Moreover, partially purified
recombinant SGT displayed specificity to sterols with hydroxyl
group at C-3 position. Functional recruitment of SGTL1 under
environmental challenge(s) has also been reported in response
to stress (Sharma et al., 2007). Further characterization of new
sterol glucosyltransferases in W. somnifera can contribute to the
disclosure of functions of various glycosterol in plants.
DIMINUTO/DWARF1 (DIM/DWF1)
DWF1 is an important gene of sterol biosynthesis and regulates
the metabolic flux by carrying out isomerization, reduction,
and epoxidation, respectively, of their immediate metabolic
precursors. DWF1 coding for key enzyme is involved in
isomerization and reduction of 24-methylene cholesterol to
campesterol and isofucosterol to sitosterol (Klahre et al., 1998).
GFP-DIM-DWF1 transient expression studies have shown that
DWF1 is an integral membrane protein and is located to ER and
not present in nucleus. Sequence homology with flavine adenine
dinucleotide-binding domain (conserved in oxidoreductases)
indicates that DWF1 has possibly a catalytic rather than
a regulatory function. Mutant studies have established the
functional role of DIM protein in plant phytosterol biosynthesis.
Other homologs of DWF1 have been characterized from
Arabidopsis thaliana, Pisum sativum, Zea mays, etc. and their
function has been elucidated by mutant studies
In one of the reports Arabidopsis DIMINUTO/DWARF1
gene was found to encode for protein involved in phytosterol
biosynthesis. Analysis of A. thaliana DIM mutant has revealed
the dwarf phenotype with decreased fertility can be restored
by addition of exogenous brassinolide. 24-Methylene cholestrol
was found to accumulate in dim mutants. All of these mutants
were deficient in campesterol, indicating toward the mutation in
DIM/DWF1 severely affects the phytosterol biosynthesis in plants
(Klahre et al., 1998).
Reports of some site directed mutants have revealed
complete loss of function of DWF1 in plants due to loss of
calmodulin binding, similarly complementation studies revealed
that fractional loss of calmodulin binding led to partial dwarf
phenotype (Du et al., 2009).
DWF1 gene homologs have been isolated from pea and
maize, and their function have been elucidated by mutant studies
The mutants have been shown to accumulate 24-methylene
cholesterol and are severely dwarfed with reduced fertility.
Biochemical and mutant studies have revealed the function
of DIM homolog in pea known as LKB. The homolog for
DIM in pea is LKB, it was observed that mutation in DIM
gene directly correlated with the altered phenotype such as
decreased enzyme activity, truncated internodal length, epinastic
leaves, and thickened stem, and accumulation of 24-methylene
cholesterol. Upon exogenous application of brassinolide the
phenotype reverted to the normal type. Northern analysis showed
the ubiquitous presence of LKB gene in the plant. Role of DWF1
is well-established in the brassinolide biosynthetic pathway.
Analysis of dim mutants has revealed that DIM mutants lead to
impaired biosynthesis of campesterol and consequent expression
of a dwarf phenotype. 24-Methylene cholestrol is a shared
precursor of both withanolide and brassinolide biosynthetic
pathway (Choe et al., 1999).
DWF1 is a multifunctional enzyme which may carry out
isomerization and reduction of post 24-methylene cholestrol
intermediates upto withanolide biosynthesis, similar to its role
in brassinolide biosynthesis. Increase in the transcript levels of
DWFI in response to MJ, 2,4-dichlorophenoxyacetic acid (2,4-D)
and SA and corresponding increase in the withanolide content
indicates toward the involvement of DWF1 in withanolide
biosynthesis along with other biosynthetic pathway genes.
Increase in the withanolide content may be due to the increase
in the 24-methylenecholestrol substrate pool which may be
a consequence of increased expression of upstream genes of
MVA pathway such as WsSQS, WsSQE, WsOSC/CS, WsOSC/LS,
WsOSC/BS,WsCPR1, andWsCPR2 upon elicitation with abiotic
factors such as MJ, 2,4-D, and SA. The presence of cis regulatory
inducible elements present in the promoter region of genes
involved in the withanolide biosynthetic pathway may be the
reason behind the effect of elicitors.
Highest amount of DWF1 transcript level were found in
leaves when compared to root and stalk tissues that corroborates
well with the high levels of withanolides accumulation in leaves
as explained in earlier studies. Also it supports the de novo
synthesis of withanolides i.e., synthesis of withanolides in various
parts of plant via complete metabolic pathway rather than
transfer from any other plant tissue. The molecular cloning
and characterization of DIM (GenBank Accession Number
KP318739) from W. somnifera and transcript profiling data
entails one of the recent studies carried out by the authors.
TISSUE-SPECIFIC TRANSCRIPTOME
ANALYSIS
More recently, for identification of putative biosynthetic pathway
genes, there has been a huge swing toward the “omics”
approach, that takes advantage of sequencing technologies to
obtain genomic and transcriptomic sequence resource. For
species where genomic data are unavailable, transcriptome
sequencing through the use of differential expression studies
is considered as a main way discovering novel genes in
non-model organisms. Against this backdrop, to aid the
basic understanding of withanolide biogenesis, transcriptome
sequencing forWithania leaf (101L) and root (101R) synthesizing
WS-3 and WS-1, respectively, has also been reported (Gupta
et al., 2013b). Pyrosequencing results have yielded 834,068
and 721,755 reads assembled into 89,548 and 114,814 unique
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sequences from 101 L and 101R. These are presumed to be
involved in synthesis of tissue-specific withanolides. Annotations
revealed all the genes involved in triterpenoid backbone
biosynthesis that incorporated MVA and MEP pathways
up to 24-methylene cholesterol, the apparent precursor for
withanogenesis. Biosynthesis of 24-methylene cholesterol is
followed by various secondary conversions including transfer of
diverse moieties or oxidation/reduction reactions for structuring
of tissue specific withanolides (Chaurasiya et al., 2012). Using
gene Ontology and KEGG analyses, members of cytochrome
P450, glycosyltransferase, and methyltransferase gene families
with restricted presence or differential leaf and root expression
have been reported. Quantification of reads for specific contig
showed 305 contigs encoding CYP450s comprising of 12 and 36
unique CYPs for leaf and root tissues that may be responsible for
the tissue specific difference in the activities counting withanolide
biosynthesis. Unigene resource generated in this study also
may be of immense value for interpretation of withanolide
biosynthetic pathway and for search of tissue specific molecular
mechanism fundamental for structuring definite withanolides
(Gupta et al., 2013b).
COMPARATIVE PROTEOME ANALYSIS
Proteomic approach encompassing research centered on two
dimensional electrophoresis (2-DE) and mass spectroscopy
(MS) presents a new system for identifying known and
unknown genes due to its ability to investigate hundreds of
proteins simultaneously (Singh et al., 2015). This feasibility of
proteomic analysis would make a considerable contribution in
understanding the complex metabolic networks of withanolide
biosynthesis in W. somnifera that could be a significant
addition to the genomic knowledge resource. As a step forward,
comprehensive 2-DE and MS analysis of in vitro grown
adventitious roots and in vivo root samples of W. somnifera was
conducted. The study showed a high similarity in protein spots
of in vitro and in vivo root samples. Thus, suggesting that in vitro
roots may have a analogous developmental route as that of in vivo
roots though these are developed independent of shoot organs
(Senthil et al., 2013). Cumulative proteome examination of leaf
and seed tissues of W. somnifera differentiated the proteome
on the basis of differential expression, count, and function
of identified and characterized tissue-specific proteins. Relative
examination of the two tissues further hinted that several proteins
of common housekeeping pathways, while a few were tissue
specific associated with definite metabolic complement (Dhar
et al., 2012). Further, studies on low, abundant and poor soluble
proteins would help in characterization of unknown pathway
genes that are responsible for the production of withanolides.
Characterization of genes, their high throughput metabolic
profiling, sequence resource and proteome information not only
provides an insight into the withanolide biosynthetic pathway
but also offers molecular wherewithals for biotechnological
improvement of W. somnifera. However, in-depth knowledge
about withanogenesis still remains elusive and all these results
in totality could be useful to reveal various underlying signal
transduction pathways to identify specific transcription factors in
addition to uncharacterized downstream pathway genes. Further,
such biosynthetic genes along with the transcription factors can
become prospective targets for pathway engineering.
TISSUE CULTURE APPROACHES FOR
WITHANOLIDE PRODUCTION
Immense therapeutic value of W. somnifera attracts exploration
of all possible approaches covering both recombinant DNA
techniques and in vitro methods for obtaining chemotypes
with desired enhanced chemoprofiles. Recombinant DNA or
cell fusion techniques are viable alternatives, but are hampered
by the lack of genetic and biochemical knowledge regarding
the biosynthesis of secondary metabolites (Evans and Sharp,
1986). Thus, demanding immediate biotechnological advances to
enhance the yield at a reduced time gap. On the other hand, in
search of alternatives, in vitro techniques present a feasible option
for the production of these therapeutically valuable compounds.
Tissue culture techniques deliver unceasing, consistent, and
renewable source of valued plant pharmaceuticals utilized for
the large-scale culture of the plant cells necessary for extraction
of secondary metabolites. Substantial work has been reported
using different types of in vitro strategies for W. somnifera
with main emphasis on manipulation of plant growth regulator
adjuvants and cultural conditions for withanolide accumulation.
The prospect of application of in vitro methods to produce
cell/organ/root cultures for enhanced withanolide production is
reviewed below.
CELL SUSPENSION CULTURE
Various withanolides correspond to a very minor percentage of
total withanolide content in the native plant. Investigation of
condition adjusted cultures for resourceful in vitro biogeneration
of such pharmacologically promising withanolides is important.
Withanolide D, WS-1, WS-3, and WS-2 production have been
described in organogenic cultures (Roja et al., 1991; Banerjee
et al., 1994; Ray et al., 1996; Vitali et al., 1996; Ray and Jha,
1999; Furmanowa et al., 2001; Sangwan et al., 2007; Murthy
et al., 2008). Several reports on accumulation of withanolide D
and WS-3 in transformed roots/shooty teratomas cultures are
also present, however WS-1 was reported to be absent in these
cultures (Banerjee et al., 1994; Ray and Jha, 1999). Successful
establishment of cell suspension cultures of W. somnifera for
biogenesis of WS-1 has been reported and optimized for its
enhanced accumulation.
Highest WS-1 content (1.27mg g−1 DWB) was observed in
suspension cultures supplemented with 2.0mg L−1 2,4-D, and
2.0mg L−1 2,4-D + 0.5mg L−1 kinetin (KN). Thus, revealing
that combination of 2,4-D with kinetin is the most suitable
for enhanced WS-1 production. It has also been reported a
combination of 1.0 ppm benzylaminopurine plus 0.5 ppm kinetin
responsible for highest accumulation of WS-1 (14.3mg per 100 g
fresh weight and 238mg per 100 g DWB, i.e., 0.24%) with the
shoot cultures of W. somnifera (Table 2; Sangwan et al., 2007).
Growth kinetics study of W. somnifera cell suspension cultures
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revealed maximum accumulation of biomass (11.02 g L−1 of
DWB) and withanolide A (2.03mg g−1 DWB) at the end of the
fourth week. Therefore, making it clear that the biomass growth
is closely concurrent with WS-1 amassing. Inoculum density of
10 g L1 was found to be the most suitable for maximum biomass
(10.88 g L−1 DWB) and highest production of withanolide A
(2.42mg g−1 DWB). Among the different medias like Murashige
and Skoog (MS), B5, NN, and N6, highest accumulation of
WS-1 (2.39mg g−1 DWB) was observed with full strength MS
medium suspension culture supplemented with 3% sucrose with
an initial medium pH of 6.0 (Table 2; Nagella and Murthy,
2010).
Investigations have also been carried on the biotransformation
capacity of cell suspension cultures generated fromW. somnifera
leaf using WS-1, WS-3, and WS-2 as precursor substrates.
Interestingly, there was a noticeable inter-conversion of WS-1
to WS-2, and vice versa involving substitution of 20-OH group
to 17-OH in WS-1 (Sabir et al., 2011). It displays the potential
of suspension cultures of W. somnifera for the production of
withanolides with multifactorial modulations.
IN VITRO SHOOT CULTURE
Root specific production of WS-1 makes root cultures,
particularly hairy roots, and its bioreactor based upscaling
the foremost way for its in vitro production. However, presence
of WS-1 has not been detected in Agrobacterium rhizogene-
transformed hairy roots of W. somnifera (Banerjee et al., 1994;
Ray and Jha, 1999). Withanolides detected in these hairy root
cultures have been reported to be predominantly produced by
the aerial parts. Therefore, WS-1 biogenesis was explored in W.
somnifera shoot cultures that are the tissue culture complements
of the aerial parts of the native plant. Shoot cultures were
initiated using explants from the two experimental lines of
W. somnifera (Ashwagandha)-RS Selection-1 (RS-Sel-1) and
RS Selection-2 (RS-Sel-2) on MS medium with different plant
growth regulators. RS-Sel-1 raised shoot culture supplemented
with benzylaminopurine (BAP) 1.00 ppm and KN 0.50 ppm
showed the highest concentration of WS-1 (14.3mg per 100 g
fresh weight and 238mg per 100 g dry weight, i.e., 0.24%) in the
green shoots (Table 2). Investigative quantities of green shoot
cultures (0.24% DWB) was more as compared to the isolation
yields of dried roots of field-grown plants. Solid mass/shooty
teratoma of RS-Sel-1 raised shoot culture also displayed the
highest concentration of WS-1 production (3.7mg per 100 g
fresh weight; 46.2mg per 100 g dry weight) with BAP 1.00 ppm
and kinetin 0.50 ppm. Comparatively, RS-Sel-1 proved to have
superior biogenesis/accumulation of WS-1 than RS-Sel-2.
Radioactivity fed shoot cultures as well led to isolation of almost
pure radiolabeledWS-1 and pointed toward de novo biosynthesis
of WS-1 in the in vitro shoot cultures (Sangwan et al., 2007).
The effect of hormones, culture conditions and elicitations
on the production of withanolides in multiple shoot cultures of
W. somnifera has also been reported. Elicitation with salicylic
acid at 100µM in combination with 0.6mg L−1 6-benzyladenine
and 20mg L−1 spermidine for 4 h at the fourth week in 20ml
liquid medium reported 1.14− to 1.18-fold higher withanolide
production in comparison to the elicitation treatment with MJ
at 100µM after 5 weeks of culture (Table 2; Sivanandhan et al.,
2013). Hence, confirming in vitro shoot culture biosystems as an
alternative amenable to fine-tuning for harvesting therapeutically
valuable WS-1 in comparison to field grown plants. Shoot
cultures also represent a suitable system for functional genomic
studies of withanolides.
ROOT CULTURE
Hairy (transformed) roots mediated with A. rhizogenes holds
immense potential for studies on secondary metabolite
biosynthesis as rapid growth and extensive branching with
genetic stability is their characteristic feature. They also exhibit
capability of synthesizing root specific secondary metabolites
(Giri and Narasu, 2000; Hu and Du, 2006). Consequently,
hairy roots in numerous aromatic and medicinal plants for
the production of significant secondary compounds have been
induced (Le Flem-Bonhomme et al., 2004; Zhao et al., 2004;
Santos et al., 2005). Murthy et al. (2008) reported transformation
of W. sominifera with A. rhizogenes strain R1601 and obtained
transformed hairy roots from cotyledons and leaf explants. Four
clones of hairy roots differing in morphology were established.
MS-based liquid medium supplemented with 40 g/L sucrose
proved to be optimum for biomass building. WS-1 content was
found to be 2.7-fold higher in transformed roots (line 3) in
comparison to non-transformed roots (Table 2; Murthy et al.,
2008).
Leaf derived callus of W. somnifera has also been used
for development of adventitious root cultures in MS half-
strength medium supplemented with 0.5mg L−1 indole-3-
butyric acid (IBA) and 0.1mg L−1 indole-3-acetic acid (IAA)
with 2% sucrose. These adventitious root cultures were
further elicited with MJ and SA autonomously to investigate
the improvement in the productivity of withanolides. Root
biomass (11.70 g FWB) on 30-day-old adventitious root cultures
treated with 150µM SA for 4 h resulted in the production
of 64.65mg g−1 DWB WS-1 (48-fold), 33.74mg g−1 DWB
withanolide B (29-fold), 17.47mg g−1 DWB WS-3 (20-
fold), 42.88mg g−1 DWB WS-2 (37-fold), 5.34mg g−1 DWB
12-deoxy withastramonolide (nine-fold), 7.23mg g−1 DWB
withanoside V (seven-fold), and 9.45mg g−1 DWB withanoside
IV (nine-fold) following elicitation of 10 days (40th day
of culture) in comparison to untreated cultures (Table 2).
Withanolide production was found to be dependent on biomass,
culture age of the adventitious roots, elicitation concentration
and time period involved (Sivanandhan et al., 2012). Thus,
highlighting the considerable potential of transformed roots and
adventitious roots of W. somnifera with further scale-up in
bioreactors.
SOMACLONAL VARIANTS
Somaclonal variation can be either genetic or epigenetic in
origin (Larkin and Scowcroft, 1981; Lee and Phillips, 1988).
The occurrence of somaclonal variation is often associated with
activation of transposable elements (Skirvin et al., 1994), point
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TABLE 2 | In vitro studies in Withania somnifera in relation to withanolides production.
In vitro strategy used Effect on withanolide levels References
CELL SUSPENSION CULTURE
(a) Supplementation with 2.0mg L−1 2,4-D and
2.0mg L−1 2,4-D + 0.5mg L−1 kinetin
(b) Supplementation with 1.0 ppm
benzylaminopurine plus 0.5 ppm kinetin
(c) Murashige and Skoog medium suspension
culture supplemented with 3% sucrose
(a) 1.27mg g−1 DWB of WS-1
(b) 14.3mg/100 gm fresh weight and
238mg/100 gm DWB of WS-1
(c) 2.39mg g−1 DWB of WS-1
https://www.jstage.jst.go.jp/article/cpb/55/9/55_9_
1371/_article
http://www.sciencedirect.com/science/article/pii/
S0960852410005559
IN VITRO SHOOT CULTURE
(a) Supplementation with 1.00 ppm
benzylaminopurine and 0.50 ppm kinetin
(b) Elicitation with salicylic acid at 100µM in
combination with 0.6mg L−1 6-benzyladenine
and 20mg L−1 spermidine
(a) 14.3mg per 100 g FWB and 238mg
per 100 g DWB of WS-1
(b) 1.14− to 1.18-fold higher withanolide
production
http://jlc.jst.go.jp/JST.JSTAGE/cpb/55.1371?from=
Google
http://link.springer.com/article/10.1007/s11738-
012-1112-x#page-1
ROOT CULTURE
(a) MS-based liquid medium supplemented with
40 g/L sucrose for hairy roots
(b) Adventitious root cultures elicited with 150µM
salicylic acid
(a) 2.7-fold higher WS-1 (b) 64.65mg g−1
DWB of WS-1 (48-fold), 33.74mg g−1
DWB of withanolide B (29-fold), 17.47mg
g−1 DWB WS-3 (20-fold), 42.88mg g−1
DWB WS-2 (37-fold), 5.34mg g−1 DWB
12-deoxy withastramonolide (nine-fold),
7.23mg g−1 DWB withanoside V
(seven-fold), and 9.45mg g−1 DWB
withanoside IV
http://onlinelibrary.wiley.com/doi/10.1111/j.1744-
7909.2008.00680.x/full
http://link.springer.com/article/10.1007/s12010-
012-9809-2#page-1
SOMACLONAL VARIANTS
Somaclonal variants Somaclonal variant regenerated with
0.516% (DWB) of
12-deoxywithastramonolide
http://link.springer.com/article/10.1007/s11627-
012-9458-8
mutation, chromosomal rearrangement, recombination, DNA
methylation, and altered sequence copy number. Somaclonal
variation is influenced by explant type, culture medium,
genotype, and the age of the donor plant, among other factors
(Skirvin et al., 1994). It has been suggested that the frequency
of somaclonal variation from cell culture is much higher
than from field-grown plants because of a, higher rate of
mutagenesis (Ahloowalia, 1986). Many plants regenerated via
indirect organogenesis have shown somaclonal variation for a
wide array of characteristics and this variation have been used
to develop new varieties in some species, like tomato, sorghum,
sugarcane, and chrysanthemum (Compton and Veilleux, 1991;
Duncan et al., 1995; Jalaja et al., 2006; Miñano et al., 2009).
Somaclonal variation could unleash the natural variability
for withanolide production and accumulation, and could be
exploited by breeders to developW. somnifera varieties attracting
commercial interest.
Rana et al. (2012) investigated and validated the applicability
of an in vitro strategy to induce somaclonal variation in W.
somnifera which manifested in the form of enhanced levels of 12-
deoxywithastramonolide (WS-12D). Variations were examined
in 54 regenerated plants obtained through indirect organogenesis
from leaf explants. WS-R-1 somaclone displayed considerably
elevated levels of WS-12D; 0.516% DWB in comparison to
the explant donor mother plant (0.002% DWB). Somaclonal
variations were investigated at cytological level, by investigating
meiosis and mitosis in comparison to number of chromosome
and structural organization. Chromosome phenotypes, somatic
chromosome count, or meiotic behavior showed no alterations.
Further, several genetic polymorphisms between explant donor
mother plant and WS-12D over-producing somaclone was
examined by random amplification of polymorphic DNA
(RAPD) study. WS-R-1 somaclone was evaluated for 2 years
to confirm genetic and chemical stability. This study supports
the feasibility of an in vitro strategy for chemotypic variability
induction to develop high-yielding clones considering the
molecular instability displayed by W. somnifera. It also widens
the genetic resource base for manipulative hybridization for
quantitative chemotypic novelty in W. somnifera (Rana et al.,
2012).
FUTURE PROSPECTS
W. somnifera has enjoyed a long and important history
in traditional medicine system wherein withanolides are
attributed with significant remedying properties. Nevertheless,
withanolide biosynthesis is still in its infancy with regard
to being understood in entirety that enormously hampers
the exploitation of its full biotechnological potential. Though,
investigations at molecular and in vitro levels have begun,
but we are still a long way from understanding how diverse
withanolides are synthesized and regulated in W. somnifera.
However, the gene elucidation data, omics resource and
in vitro study inferences generated so far offers significant
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promise for enormous increase in correct annotation, functional
characterization of enzymes and for comprehending the
assorted interactions amongst sophisticated biosynthetic and
regulatory mechanisms crucial for successful implementation
of withanolide metabolic engineering strategies. Furthermore,
advancing metabolic engineering technologies for transgenics,
precursor feeding, gene overexpression and inhibition and
mutant selection in W. somnifera still awaits investigation.
There is much to be learned about the chemical ecology
of withanolides to answer an important question about their
evolution in the form of sophisticated and diverse structures
and types. Though, anticipation about withanolides acting as
growth regulators owing to their partial coinciding biosynthetic
route with brassinosteroids do exist, but it further demands in-
depth examination to build a framework for elaborate pathway
modulation strategies.
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